Indivior Pharmaceuticals, Inc. (INDV)
37.53
+0.07
(+0.19%)
USD |
NASDAQ |
May 22, 16:00
37.55
+0.02
(+0.05%)
After-Hours: 20:00
Indivior Pharmaceuticals EPS Diluted (Quarterly) : 0.6899 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.276 |
| Liquidia Corp. | 0.5228 |
| Viatris, Inc. | 0.1501 |
| Catalyst Pharmaceuticals, Inc. | 0.5022 |
| Theravance Biopharma, Inc. | -0.0962 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 89.00M |
| Revenue (Quarterly) | 317.00M |
| Total Expenses (Quarterly) | 228.00M |
| Enterprise Value | 4.770B |
| Gross Profit Margin (Quarterly) | 87.38% |
| Profit Margin (Quarterly) | 28.08% |
| Earnings Yield | 5.26% |
| Operating Earnings Yield | 9.17% |
| Normalized Earnings Yield | 7.177 |